Suzhou Suncadia Biopharmaceuticals Co., Ltd. clinical trial pipeline

7 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 7 with minor changes only.

1. Minor

   SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large…SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

   Enrollment closed, study ongoing

   Suzhou Suncadia Biopharmaceuticals Co., Ltd.·Phase 3· NCT06929624· Registry history of NCT06929624 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

2. Minor

   SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for…SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC

   Enrollment closed, study ongoing

   Suzhou Suncadia Biopharmaceuticals Co., Ltd.·Phase 3· NCT07183189· Registry history of NCT07183189 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

3. Minor

   SHR-4685 on Safety, Tolerability and Pharmacokinetics · Solid…SHR-4685 on Safety, Tolerability and Pharmacokinetics · Solid Tumors

   Trial sites expanded: 1 → 6 locations

   Suzhou Suncadia Biopharmaceuticals Co., Ltd.·Phase 1· NCT07676903· Registry history of NCT07676903 on ClinicalTrials.gov (opens the registry)

   Oct 5, 2026

4. Minor

   TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab…TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE · Incurable Hepatocellular Carcinoma

   Interventions modified

   Suzhou Suncadia Biopharmaceuticals Co., Ltd.·Phase 3· NCT07691762· Registry history of NCT07691762 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

5. Minor

   SHR-8068 Combined With Adebrelimab and Bevacizumab Versus…SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab · Advanced Hepatocellular Carcinoma (KYLIN-02)

   Interventions modified

   Suzhou Suncadia Biopharmaceuticals Co., Ltd.·Phase 3· NCT06618664· Registry history of NCT06618664 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

6. Minor

   2 trials marked Unknown by the registry's verification sweep

   1. Minor

      Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low &…Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

      Suzhou Suncadia Biopharmaceuticals Co., Ltd.·Phase 2· NCT06592625· Registry history of NCT06592625 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   2. Minor

      SHR-A1921 in Combination With Other Anti-cancer Agents…SHR-A1921 in Combination With Other Anti-cancer Agents · Advanced Solid Tumors

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting

      Suzhou Suncadia Biopharmaceuticals Co., Ltd.·Phase 1/2· NCT05765032· Registry history of NCT05765032 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   Registry verification sweep

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.